NCT07453550 The Effects of Brief Periods of Exercise on Blood Pressure
| NCT ID | NCT07453550 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Hartford |
| Condition | Hypertension (HTN) |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2026-02-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
High blood pressure is a common medical condition that affects the body's arteries. It's also called hypertension. Untreated hypertension increases the risk of heart attack, stroke and other serious health problems. Exercise is a promising tool in hypertension management. Regular participation in exercise improves vascular health, heart and lung function, and multisystem health. However, the direct evidence of the treatment effects of a brief period of exercise on blood pressure in individuals with hypertension is limited. A brief period of exercise refers to an exercise protocol that only lasts for a very short period of time, such as 5-10 minutes.
Eligibility Criteria
Inclusion Criteria: * 18-55 yrs. * 24 hour average BP \>110/70 mmHg, but \< 160 systolic blood pressure * Able to provide informed consent Exclusion Criteria: * Currently taking anti-hypertensive medication smokers and alcohol drinkers Inability to undertake exercise intervention (resistance and isometric exercise) Current medical history of any of the following: hyperaldosteronism Diabetes mellitus (Type 1 or type 2) Heart disease Stroke or transient ischemic attack Peripheral neuropathy Aortic aneurysm and/or peripheral arterial disease If female, pregnancy or currently breast feeding Enrolled in another Clinical Trial of an Interventional Medicinal Product or Medical Device or other interventional study Medical condition that, in the opinion of the investigator, would make the participant unsuitable for the study On long term warfarin Allergies to blood pressure cuff materials or ultrasound gel Previous medication history of any of the following: hyperaldosteronism Heart disease Stroke or transient ischemic attack Peripheral neuropathy Aortic aneurysm and/or peripheral arterial disease thromboembolism Infection within limb within 3 months On long term warfarin Allergies to blood pressure cuff materials or ultrasound gel
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07453550 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Hypertension (HTN). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07453550 currently recruiting?
Yes, NCT07453550 is actively recruiting participants. Contact the research team at jiyang@hartford.edu for enrollment information.
Where is the NCT07453550 trial being conducted?
This trial is being conducted at West Hartford, United States.
Who is sponsoring the NCT07453550 clinical trial?
NCT07453550 is sponsored by University of Hartford. The trial plans to enroll 45 participants.